Nippon Chemiphar Co., Ltd.
Records under this name other than the patents Nippon Chemiphar Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 32 patents it holds.
Back to Nippon Chemiphar Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,963,460 | Morphinan Derivative now held by Toray Industries, Inc. In force · High confidence | In force | High confidence | |
| US 11,420,944 | Voltage-Dependent T-Type Calcium Channel Blocker held by Nippon Chemiphar Co., Ltd. and Kinki University Lapsed on the fee record Ended Aug 23, 2026 · High confidence | Lapsed on the fee record | Ended Aug 23, 2026 | High confidence |
| US 8,778,933 | Diazepinedione Derivative Lapsed on the fee record Ended Jul 15, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 15, 2026 | Medium confidence |
| US 7,598,254 | Substituted 1,3-Thiazolo[5,4-d]pyrimidines as Xanthine Oxidase Inhibitors Term ended Term ended Jun 28, 2026 · High confidence | Term ended | Term ended Jun 28, 2026 | High confidence |
| US 11,370,761 | Voltage-Dependent T-Type Calcium Channel Inhibitor held by Nippon Chemiphar Co., Ltd. and Kinki University Lapsed on the fee record Ended Jun 28, 2026 · High confidence | Lapsed on the fee record | Ended Jun 28, 2026 | High confidence |
| US 8,680,110 | P2X4 Receptor Antagonist Lapsed on the fee record Ended Mar 25, 2026 · High confidence | Lapsed on the fee record | Ended Mar 25, 2026 | High confidence |
| US 11,278,528 | Activator of Peroxisome Proliferator-Activated Receptor Lapsed on the fee record Ended Mar 22, 2026 · High confidence | Lapsed on the fee record | Ended Mar 22, 2026 | High confidence |
| US 8,673,915 | P 2 X 4 Receptor Antagonist Lapsed on the fee record Ended Mar 18, 2026 · High confidence | Lapsed on the fee record | Ended Mar 18, 2026 | High confidence |
| US 8,648,208 | Activating Agent for Peroxisome Proliferator Activated Receptor Lapsed on the fee record Ended Feb 11, 2026 · High confidence | Lapsed on the fee record | Ended Feb 11, 2026 | High confidence |
| US 9,873,683 | P2X4 Receptor Antagonist held by Nippon Chemiphar Co., Ltd. and Kyushu University Lapsed on the fee record Ended Jan 23, 2026 · High confidence | Lapsed on the fee record | Ended Jan 23, 2026 | High confidence |